Thus far, Pfizer's obesity efforts have crashed and burned. Last year, the pharmaceutical giant threw in the towel on ...

This World Cancer Day, Pfizer Canada ULC ("Pfizer"), in partnership with leading oncology patient organizations, is proud to ...

Amgen is refusing U.S. regulators’ request to withdraw an inflammatory disease drug. Elsewhere, Pfizer battled skepticism on ...

Pfizer’s experimental weight loss drug shows promise in mid-stage trial - Pfizer acquired the drug’s developer following a bidding war with Novo Nordisk last year ...

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

In lieu of a Super Bowl ad this year, Pfizer has unveiled a year-long cancer campaign that aims to encourage screening.

Neomorph begins human testing of a molecular glue therapy that selectively removes cancer-driving proteins, targeting clear cell renal cell carcinoma.

Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits, fuelled ...

The firm provided updates alongside Q4 and full-year 2025 financial results, and reported $19.29 billion and $65.18 billion ...

The global nutraceuticals market, valued at approximately USD 416 billion in 2026, is projected to grow at a CAGR of around 9% over the next five years.Key factors driving this growth include ...

Shares have mostly gained in Asia, although markets in Japan were dragged lower by selling of tech-related stocks. Gold and silver prices continued to rebound, while oil prices also gained. U.S.